436 results on '"Wardlaw, Andrew J."'
Search Results
2. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
3. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
4. Eosinophils in Health and Disease: A State-of-the-Art Review
5. Allergic fungal airways disease (AFAD): an under-recognised asthma endotype
6. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
7. Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
8. Eosinophil Interactions with Extracellular Matrix Proteins
9. The Role of Adhesion in Eosinophil Accumulation and Activation in Asthma
10. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
11. Eosinophilia in Pulmonary Disorders
12. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus–associated asthma (EVITA3 study)
13. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
14. Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology
15. DNA analysis of outdoor air reveals a high degree of fungal diversity, temporal variability, and genera not seen by spore morphology
16. Fungi and allergic lower respiratory tract diseases
17. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
18. Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12
19. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma
20. Refining the definition of hypereosinophilic syndrome
21. Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
22. Qualitative Analysis of High-Resolution CT Scans in Severe Asthma
23. New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease
24. CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers
25. Increased sputum and bronchial biopsy IL-13 expression in severe asthma
26. Reproducibility between counts of airborne allergenic pollen from two cities in the East Midlands, UK
27. Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
28. Mepolizumab and exacerbations of refractory eosinophilic asthma
29. Familial hypereosinophilia associated with eosinophilic gastrointestinal symptoms in individuals with a missense mutation in CKLF‐like MARVEL transmembrane domain containing 3
30. Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma
31. Role of eosinophils in asthma
32. Contributors
33. Evidence of a role of tumor necrosis factor alpha in refractory asthma
34. Unexplained peripheral blood eosinophilia with gastrointestinal symptoms
35. Elevated Sputum Interleukin-5 and Submucosal Eosinophilia in Obese Individuals with Severe Asthma
36. Mast-cell infiltration of airway smooth muscle in asthma
37. Advances in the Management of Severe Asthma
38. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma
39. Fungal sensitization and positive fungal culture from sputum in children with asthma are associated with reduced lung function and acute asthma attacks respectively
40. The airway fungal microbiome in asthma
41. IgE Sensitization to Aspergillus fumigatus Is Associated with Reduced Lung Function in Asthma
42. Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes
43. Characterization of the migration of lung and blood T cells in response CXCL12 in a three-dimensional matrix
44. Anti–Interleukin-5 Therapy and Severe Asthma
45. IL-4–expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR3 and CCR4
46. A new paradigm of eosinophil granulocytes: neuroimmune interactions
47. Cluster Analysis and Clinical Asthma Phenotypes
48. Human eosinophils: Apoptosis versus survival in the mediation of inflammation
49. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma
50. The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.